# An Effectiveness and Safety 6 Months Study of 3 Injections One Week Apart of SYNOLIS VA 40/80 in the Treatment of Symptomatic Knee Osteoarthritis

> **NCT05829850** · NA · COMPLETED · sponsor: **Aptissen SA** · enrollment: 51 (actual)

## Conditions studied

- Osteo Arthritis Knee

## Interventions

- **DEVICE:** SYNOLIS VA 40/80

## Key facts

- **NCT ID:** NCT05829850
- **Lead sponsor:** Aptissen SA
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-12-29
- **Primary completion:** 2023-01-09
- **Final completion:** 2023-01-09
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2023-04-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05829850

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05829850, "An Effectiveness and Safety 6 Months Study of 3 Injections One Week Apart of SYNOLIS VA 40/80 in the Treatment of Symptomatic Knee Osteoarthritis". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT05829850. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*